Distinct Progression Paths Underlie the Diversity of Pancreatic Papillary Cystic Neoplasms
Surgical decisions for intraductal papillary mucinous neoplasms (IPMNs), precursors of pancreatic cancer, depend on distinguishing low- from high-grade dysplasia, a distinction that molecular markers could refine. We microdissected 433 tumor regions from 135 patients and integrated transcriptomics, deep-learning histology, and KRAS/GNAS RNA-called variants. RNA programs and morphological motifs…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
